Lv1
40 积分 2022-01-11 加入
Autologous, allogeneic, in vivo CAR for autoimmune diseases
3个月前
已完结
CRISPR/Cas9 Genome Editing in Oncology: Mechanisms, Therapeutic Platforms and Translational Challenges
3个月前
已完结
Harnessing the potential of gene-editing technology to overcome the current bottlenecks of CAR-T cell therapy in T-cell malignancies
3个月前
已完结
Toxicologic Pathology Forum*: Opinion on Qualitative Severity Descriptors to Express Magnitude of Changes in Clinical Pathology Endpoints in Nonclinical Toxicity Studies
7个月前
已完结
皖公网安备34019202002308
